AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Shift Work on Glucose and Lipid Metabolism of Hospital Workers

Recruitingn/aAges 18 Years - 67 YearsAllOlga Ramich (formerly Pivovarova)
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to evaluate circadian glucose, activity and dietary rhythms, as well as metabolic and cardiovascular risk associated with night shift work, sleep quality and well-being in a cohort of hospital staff, comparing employees with night shifts to employees without night shifts.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Aged between 18 and 67 * Male or female * Currently employed * Body-Mass-Index (BMI) \<40 kg/m2 * Working hours ≥28 hours/week * Employees working night shifts (group A): (1) Working night shifts for \>1 year, (2) at least two night shifts within the 2-week observation period * Employees not working night shifts (group B): No night shifts for \>1 year * Capable of giving consent * Health insurance * Good knowledge of German Exclusion Criteria: * Pregnancy and breastfeeding * Special diets, e.g. intermittent fasting * Severe acute or chronic diagnosed conditions, e.g., diabetes mellitus, liver or kidney disease (e.g., cirrhosis of the liver or kidney disease with a GFR \< 60), heart attack within the last 6 months, stroke, or systemic infections; current cancer or cancer diagnosed within the last 2 years * Bariatric surgery * Hereditary or acquired blood clotting disorders * severe mental health conditions, e.g., substance use disorders, eating disorders, or uncontrolled depression (individual assessment by study staff, if necessary following consultation with a physician) * Holiday in a different time zone (≥ 2 hours time difference) one month before study participation or within the 2-week observation phase * Participation in another study that could influence the results of the current study * Specific drug therapies that could influence the study results, e.g., antidiabetic medications including GLP-1 analogs, melatonin (Individual assessment by study staff, if necessary after consultation with a physician) * Implanted electronic medical devices, e.g., pacemakers or neurostimulators (to be assessed on a case-by-case basis by study staff, following consultation with a physician if necessary) * Physical or mental difficulties in understanding and following instructions from study staff
💊

What it tests

  • Not listed
📍

Where

2 sites
Charité - Universitätsmedizin Berlin, CharitéCentrum für Anästhesiologie und Intensivmedizin (CC 07) + CIP - Charité Intensivpflege
Berlin, Germany
Charité-Universitaetsmedizin Berlin, Department of Anesthesiology and Intensive Care Medicine (CCM/CVK)
Berlin, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy